Tessera Therapeutics: addressing Alpha-1 Antitrypsin Deficiency
At Tessera, we are building a broad toolkit of Gene Writers™ to therapeutically edit the genome. Our RNA Gene Writers are designed to efficiently introduce a range of genomic changes from small nucleotide substitutions to exon or gene-sized fragments using all‑RNA compositions.
Tessera Therapeutics: addressing Alpha-1 Antitrypsin Deficiency Read More »